{'Year': '2016'}
Influence of CYP3A5 polymorphism on the pharmacokinetics of psychiatric drugs.
The contribution of the CYP3A5 enzyme to the metabolism of clinically used drugs has been established only for a few CYP3A substrates, such as the immunosuppressant tacrolimus, while for drugs used in the field of psychiatry its role is still vague.